Market Creation for Life Sciences

We build the market
your science deserves.

FTP Blueprint™ delivers the integrated policy, public affairs, and commercial strategy that turns federal exposure into enterprise value.

In life sciences, the most consequential commercial decisions are made in Washington.

FDA approvals. CMS reimbursement frameworks. Congressional oversight. State coverage decisions. Your enterprise value is federally exposed. FTP Blueprint™ creates the political, regulatory, and commercial conditions that determine whether a billion-dollar product ever reaches its potential.

The Stakeholders That Shape Markets

Policymakers

Congress, the Executive Branch, and federal agencies

KOLs

Clinical validators who shape prescribing and perception

Patients

Advocates who create demand and political urgency

Payers

CMS and private insurers who determine coverage

Investors

Capital markets that reward policy leadership

A Comprehensive, Fully Integrated
Market Access Campaign

Federal Strategy

Executive Branch, Congressional, and agency engagement designed as a coordinated campaign across all branches of government.

Market Access

CMS coding and reimbursement strategy, payer engagement, coverage pathways, and the federal foundation that commercial success depends on.

Commercial Strategy

Go-to-market architecture, launch execution, sales infrastructure, and investor positioning that converts policy advantage into enterprise value.

Demand Creation

KOL mobilization, patient advocacy, coalition building, and field operations across all 50 states that create market pull and political urgency.

Investor & Board Strategy

Capital markets positioning, IR support, and strategic narrative development that strengthens conviction and accelerates the path to partnership or acquisition.

Risk & Crisis Defense

Bipartisan positioning, political risk management, and rapid response capability. Prepared for whatever comes next.

The market doesn't appear on its own. We create it.

FTP Blueprint™ builds the political, regulatory, and commercial conditions that determine whether your investments in science and growth translate into market value.